NASDAQ:RNAZ | Balance Sheet | Transcode Therapeutics, Inc.

Complete source-backed balance-sheet history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical Balance Sheet

DateCash and equivalentsCurrent securitiesReceivablesInventoryOther current assetsCurrent assetsProperty, plant and equipmentOther noncurrent assetsTotal assetsAccounts payableCurrent liabilitiesLong-term debtOther noncurrent liabilitiesTotal liabilitiesShareholder equity
2026-06-30$8.38M$10.64M$322,809.00$151.01M$5.4M$12.65M-$27.69M
2026-03-31$12.84M$16.75M$346,745.00$157.16M$5.38M$12.64M$1.25M
2025-12-31$17.81M$21.98M$370,681.00$162.4M$3.49M$10.52M$10.34M
2025-09-30$2.84M$4.75M$19,908.00$5.23M$2.97M$3.8M$1.43M
2025-06-30$7.37M$8.24M$24,689.00$8.27M$1.56M$2.12M$6.15M
2025-03-31$11.57M$13.04M$38,131.00$13.19M$2.51M$2.9M$10.29M
2024-12-31$5.81M$7.09M$51,574.00$7.29M$2.77M$9.31M-$2.02M
2024-09-30$1.88M$3.61M$61,420.00$3.94M$2.28M$2.28M$1.65M
2024-06-30$3.35M$4.39M$64,581.00$4.82M$3.5M$3.5M$1.32M
2024-03-31$4.91M$6.71M$92,379.00$7.29M$2.71M$2.71M$4.58M
2023-12-31$2.77M$4.46M$120,707.00$5.17M$3.49M$3.53M$1.64M
2023-09-30$7.45M$9.37M$152,362.00$10.23M$5.6M$5.79M$4.44M
2023-06-30$3.57M$4.89M$178,975.00$5.88M$3.52M$3.79M$2.09M
2023-03-31$1.62M$4.35M$191,837.00$5.59M$5.45M$5.83M-$236,792.00
2022-12-31$4.97M$7.38M$208,581.00$7.59M$4.35M$4.35M$3.24M
2022-09-30$8.79M$11.57M$209,871.00$12.02M$3.77M$3.77M$8.24M
2022-06-30$13.44M$13.92M$234,673.00$14.16M$1.73M$1.73M$12.43M
2022-03-31$16.85M$18.63M$215,324.00$18.85M$1.85M$1.85M$17M
2021-12-31$20.83M$22.73M$206,268.00$22.94M$2.53M$2.53M$20.4M
2021-09-30$22.5M$481,565.00$25.2M$155,610.00$25.36M$2.2M$2.2M$23.16M
2021-06-30$79,567.00$540,219.00$91,594.00$1.52M$1.53M$6.56M-$5.04M
2021-03-31$98,962.00-$7.85M
2020-12-31$828,016.00$831,215.00$1.06M$404,862.00$4.46M-$3.41M
2020-09-30$1.1M-$2.62M
2020-06-30$1.29M-$1.28M
2020-03-31-$1.15M
2019-12-31$204,471.00-$1.11M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.